Hosseini-khah, Z.; Babaei, M.R.; Tehrani, M.; Cucchiarini, M.; Madry, H.; Ajami, A.; Rakhshani, N.; Rafiei, A.; Nikbin, B.
SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Curr. Oncol. 2021, 28, 3015-3029.
https://doi.org/10.3390/curroncol28040264
AMA Style
Hosseini-khah Z, Babaei MR, Tehrani M, Cucchiarini M, Madry H, Ajami A, Rakhshani N, Rafiei A, Nikbin B.
SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology. 2021; 28(4):3015-3029.
https://doi.org/10.3390/curroncol28040264
Chicago/Turabian Style
Hosseini-khah, Zahra, Mohammad Reza Babaei, Mohsen Tehrani, Magali Cucchiarini, Henning Madry, Abolghasem Ajami, Nasser Rakhshani, Alireza Rafiei, and Behrooz Nikbin.
2021. "SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression" Current Oncology 28, no. 4: 3015-3029.
https://doi.org/10.3390/curroncol28040264
APA Style
Hosseini-khah, Z., Babaei, M. R., Tehrani, M., Cucchiarini, M., Madry, H., Ajami, A., Rakhshani, N., Rafiei, A., & Nikbin, B.
(2021). SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology, 28(4), 3015-3029.
https://doi.org/10.3390/curroncol28040264
